The global surgical robot manufacturer Intuitive Surgical recently released its Q4 2025 earnings report. The report shows that the company's revenue for the quarter reached $2.87 billion, a year-on-year increase of 19%, surpassing the market analysts' general expectation of $2.75 billion.

In terms of profitability, the company's adjusted earnings per share for the quarter were $2.53, also exceeding the analysts' expectation of $2.26. Regarding core business metrics, the volume of robot-assisted procedures, including those performed with the da Vinci Surgical System and the Ion surgical system, increased by approximately 18% year-on-year in the fourth quarter.

Based on current market performance and expectations, the company provided an outlook for its 2026 business growth, anticipating that global procedure volume assisted by its da Vinci systems will grow by 13% to 15%. For comparison, the company's related procedure volume grew by 18% for the full year 2025.

The better-than-expected performance this quarter is primarily attributed to the continued global expansion of clinical applications for its core surgical robotics platform. The report reflects that the acceptance and usage of robot-assisted minimally invasive surgery in clinical treatment continue to show steady growth.